Fresenius medical care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter

Continued solid organic growth in care enablement and care delivery including sequentially stable same market treatment growth in the u.s. successful execution on turnaround plan driving productivity improvements in care delivery and pricing in care enablement fme25 transformation savings fully on track continued execution on portfolio optimization strategy fy 2023 earnings outlook raised waltham, mass. , nov. 1, 2023 /prnewswire/ -- helen giza, chief executive officer of fresenius medical care, said: "our unwavering focus on executing against our strategic plan and the successful implementation of turnaround measures to date, continue to translate into improved operating performance.
FMS Ratings Summary
FMS Quant Ranking